43 related articles for article (PubMed ID: 8163050)
1. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871
[TBL] [Abstract][Full Text] [Related]
2. Amylin, amyloid and age-related disease.
Cooper GJ; Tse CA
Drugs Aging; 1996 Sep; 9(3):202-12. PubMed ID: 8877314
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.
Oosterwijk C; Höppener JW; van Hulst KL; Lips CJ
Int J Pancreatol; 1995 Aug; 18(1):7-14. PubMed ID: 7594773
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of amylin and amylin deficiency.
Kruger DF; Gatcomb PM; Owen SK
Diabetes Educ; 1999; 25(3):389-97; quiz 398. PubMed ID: 10531859
[TBL] [Abstract][Full Text] [Related]
5. Amylin regulation of fuel metabolism.
Young AA
J Cell Biochem; 1994; 55 Suppl():12-8. PubMed ID: 7929614
[TBL] [Abstract][Full Text] [Related]
6. Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans.
Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR
Diabetologia; 1994 Feb; 37(2):166-9. PubMed ID: 8163050
[TBL] [Abstract][Full Text] [Related]
7. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
Koopmans SJ; van Mansfeld AD; Jansz HS; Krans HM; Radder JK; Frölich M; de Boer SF; Kreutter DK; Andrews GC; Maassen JA
Diabetologia; 1991 Apr; 34(4):218-24. PubMed ID: 2065857
[TBL] [Abstract][Full Text] [Related]
8. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.
Frontoni S; Choi SB; Banduch D; Rossetti L
Diabetes; 1991 May; 40(5):568-73. PubMed ID: 2022302
[TBL] [Abstract][Full Text] [Related]
9. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.
Gulli G; Rossetti L; DeFronzo RA
Metabolism; 1997 Oct; 46(10):1157-61. PubMed ID: 9322799
[TBL] [Abstract][Full Text] [Related]
10. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats.
Hettiarachchi M; Chalkley S; Furler SM; Choong YS; Heller M; Cooper GJ; Kraegen EW
Am J Physiol; 1997 Nov; 273(5):E859-67. PubMed ID: 9374670
[TBL] [Abstract][Full Text] [Related]
11. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
[TBL] [Abstract][Full Text] [Related]
12. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.
Wang ZL; Bennet WM; Ghatei MA; Byfield PG; Smith DM; Bloom SR
Diabetes; 1993 Feb; 42(2):330-5. PubMed ID: 8425669
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.
Cooper GJ; Willis AC; Clark A; Turner RC; Sim RB; Reid KB
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8628-32. PubMed ID: 3317417
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques.
Johnson KH; O'Brien TD; Hayden DW; Jordan K; Ghobrial HK; Mahoney WC; Westermark P
Am J Pathol; 1988 Jan; 130(1):1-8. PubMed ID: 3276206
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.
Leighton B; Cooper GJ
Nature; 1988 Oct; 335(6191):632-5. PubMed ID: 3050530
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
